CVS Health (CVS) – Research Analysts’ Recent Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of CVS Health (NYSE: CVS) in the last few weeks:

• 8/6/2026 – CVS Health was given a new $107.00 price target by Robert W. Baird.
• 8/6/2026 – CVS Health had its price target raised by UBS Group AG from $122.00 to $126.00. They now have a “buy” rating on the stock.
• 8/6/2026 – CVS Health had its price target raised by Barclays PLC from $106.00 to $108.00. They now have an “overweight” rating on the stock.
• 8/5/2026 – CVS Health was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 7/24/2026 – CVS Health had its price target raised by UBS Group AG from $115.00 to $122.00. They now have a “buy” rating on the stock.
• 7/23/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/20/2026 – CVS Health was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 7/15/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/14/2026 – CVS Health had its price target raised by Truist Financial Corporation from $108.00 to $118.00. They now have a “buy” rating on the stock.
• 7/13/2026 – CVS Health had its price target raised by Wells Fargo & Company from $103.00 to $123.00. They now have an “overweight” rating on the stock.
• 7/9/2026 – CVS Health had its price target raised by Royal Bank Of Canada from $107.00 to $113.00. They now have an “outperform” rating on the stock.
• 7/7/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/7/2026 – CVS Health had its price target raised by Cantor Fitzgerald from $100.00 to $110.00. They now have an “overweight” rating on the stock.
• 7/6/2026 – CVS Health had its “hold” rating reaffirmed by HSBC Holdings plc. They now have a $103.00 price target on the stock.
• 6/29/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 6/22/2026 – CVS Health had its price target raised by Bank of America Corporation from $100.00 to $110.00. They now have a “buy” rating on the stock.
• 6/21/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/13/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 6/11/2026 – CVS Health had its “overweight” rating reaffirmed by Cantor Fitzgerald.
• 6/8/2026 – CVS Health had its price target raised by Mizuho from $110.00 to $115.00. They now have an “outperform” rating on the stock.
• 6/8/2026 – CVS Health had its price target raised by UBS Group AG from $100.00 to $115.00. They now have a “buy” rating on the stock.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s dividend payout ratio is 70.37%.

Insider Buying and Selling

In other news, Director Larry Robbins sold 1,983,538 shares of the stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total transaction of $187,345,164.10. Following the transaction, the director owned 6,213,261 shares of the company’s stock, valued at approximately $586,842,501.45. This represents a 24.20% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In the last quarter, insiders sold 3,372,000 shares of company stock worth $317,473,598. Company insiders own 0.85% of the company’s stock.

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.